APA (7th ed.) Citation

Kaplan, A., Stewart, D. J., Batist, G., Spadafora, S., Sehdev, S., & Goodman, S. G. (2022). Access Denied? The Unintended Consequences of Pending Drug Pricing Rules. Current Oncology, 29(4), 2504. https://doi.org/10.3390/curroncol29040204

Chicago Style (17th ed.) Citation

Kaplan, Alan, David J. Stewart, Gerald Batist, Silvana Spadafora, Sandeep Sehdev, and Shaun G. Goodman. "Access Denied? The Unintended Consequences of Pending Drug Pricing Rules." Current Oncology 29, no. 4 (2022): 2504. https://doi.org/10.3390/curroncol29040204.

MLA (9th ed.) Citation

Kaplan, Alan, et al. "Access Denied? The Unintended Consequences of Pending Drug Pricing Rules." Current Oncology, vol. 29, no. 4, 2022, p. 2504, https://doi.org/10.3390/curroncol29040204.